Dr. Anita Ambikapathy:

I will make two points. On the time limit, we have seen in a lot of the literature that the six-month or three-month limit with regard to how long somebody thinks they have to live is difficult in the medical field, and all of us understand that. Time limiting how quickly one will die from illness is very difficult.

The second part is more about safeguarding robustness and how, even should that happen in the time limit we talked about, all the literature internationally states that as much as safeguards have been put in to decide about capacity, severity, and the close time to a certain illness with no other therapeutical interventions, these have not been classified as being robust enough. It would be safe to say that in respect of every jurisdiction. The difficulty we are grappling with is how best to ring-fence and how best to legislate, which is where we are and why we are here. That is still being struggled with worldwide after decades and decades.